Related Experiment Video
Updated: Jul 13, 2026
07:31
Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Published on: November 1, 2014
Anti-IgE as a mast cell-stabilizing therapeutic agent
1Institute of Biotechnology, National Tsing Hua University, Genomics Research Center, Academia Sinica, Taipei, Taiwan. twchang@gate.sinica.edu.tw
The Journal of Allergy and Clinical Immunology
|June 6, 2006
Summary
Humanized monoclonal anti-immunoglobulin E (IgE) antibodies effectively treat allergic conditions by downregulating IgE receptors on mast cells. This makes inflammatory cells insensitive to allergens, offering a novel therapeutic approach.
Area of Science:
- Immunology
- Allergology
- Pharmacology
Background:
- Humanized monoclonal anti-immunoglobulin E (IgE) antibodies have undergone extensive clinical trials.
- Omalizumab is approved for moderate-to-severe allergic asthma in patients aged 12+.
Purpose of the Study:
- To elucidate the immunoregulatory effects of anti-IgE antibodies beyond simple IgE neutralization.
- To characterize the mechanism of action of anti-IgE in allergic diseases.
Main Methods:
- Analysis of data from approximately 20 Phase II and III clinical trials.
- Investigation of the effects of anti-IgE on IgE Fc receptors (FcepsilonRI) on mast cells and basophils.
Main Results:
- Anti-IgE therapy depletes free IgE, leading to downregulation of FcepsilonRI on mast cells and basophils to <5% within weeks to months.
- This downregulation renders inflammatory cells insensitive to allergen stimulation.
- Therapeutic anti-IgE functions as a mast cell-stabilizing agent by reducing FcepsilonRI density.
Conclusions:
- Therapeutic anti-IgE represents a new class of mast cell-stabilizing agents.
- Its mechanism involves reducing FcepsilonRI density, leading to allergen insensitivity.
- This contrasts with cromones, which inhibit intracellular signaling pathways.
Related Concept Videos
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
00:42Cross-reactivity
Overview
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...